Catalyst

Slingshot members are tracking this event:

Paratek (PRTK) Plans to Submit New Drug Application in H1 2018 for Omadacycline in Treatment of Community Acquired Bacterial Pneumonia (CABP)

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
PRTK

100%
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jan 03, 2018
Occurred Source:
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords New Drug Application, Omadacycline, Community Acquired Bacterial Pneumonia, Cabp, Fda